| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 32 |
| 1 | INFLIXIMAB | 25 |
| 2 | PREDNISONE | 23 |
| 3 | INFLIXIMAB-DYYB | 21 |
| 4 | TESTOSTERONE | 17 |
| 5 | PANTOPRAZOLE | 16 |
| 6 | OCRELIZUMAB | 13 |
| 7 | SECUKINUMAB | 10 |
| 8 | UPADACITINIB | 10 |
| 9 | VITAMIN C | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 21 | 0.0061 |
| 1 | ALMOTRIPTAN | 2 | 0.0019 |
| 2 | ADALIMUMAB-AFZB | 5 | 0.0019 |
| 3 | SEBETRALSTAT | 1 | 0.0019 |
| 4 | CLINDAMYCIN PHOSPHATE | 8 | 0.0014 |
| 5 | GARADACIMAB | 1 | 0.0013 |
| 6 | AZATHIOPRINE SODIUM | 3 | 0.0012 |
| 7 | TERBUTALINE SULFATE | 2 | 0.0011 |
| 8 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 9 | BESIFLOXACIN | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 51 |
| 1 | Corticosteroid [EPC] | 36 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 3 | Androgen [EPC] | 17 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 5 | Benzodiazepine [EPC] | 15 |
| 6 | Interleukin-23 Antagonist [EPC] | 14 |
| 7 | Vitamin C [EPC] | 12 |
| 8 | Janus Kinase Inhibitor [EPC] | 11 |
| 9 | Interleukin-17A Antagonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Androgen [EPC] | 17 | 0.0006 |
| 2 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 4 | Interleukin-17A Antagonist [EPC] | 10 | 0.0003 |
| 5 | Prostaglandin E1 Analog [EPC] | 4 | 0.0002 |
| 6 | Nitrofuran Antibacterial [EPC] | 4 | 0.0002 |
| 7 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 8 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 9 | Aluminum Complex [EPC] | 4 | 0.0002 |